Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Neurogene Inc (NASDAQ: NGNE) closed at $40.00 down -44.08% from its previous closing price of $71.53. In other words, the price has decreased by -$44.08 from its previous closing price. On the day, 1.99 million shares were traded. NGNE stock price reached its highest trading level at $49.37 during the session, while it also had its lowest trading level at $35.6.
Ratios:
For a deeper understanding of Neurogene Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.17 and its Current Ratio is at 12.17. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on June 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $65.
On June 11, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $54.
On April 29, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $46.Leerink Partners initiated its Outperform rating on April 29, 2024, with a $46 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NGNE now has a Market Capitalization of 593144000 and an Enterprise Value of 379624512. For the stock, the TTM Price-to-Sale (P/S) ratio is 558.86 while its Price-to-Book (P/B) ratio in mrq is 3.35. Its current Enterprise Value per Revenue stands at 410.405 whereas that against EBITDA is -5.799.
Stock Price History:
Over the past 52 weeks, NGNE has reached a high of $74.49, while it has fallen to a 52-week low of $12.49. The 50-Day Moving Average of the stock is -14.73%, while the 200-Day Moving Average is calculated to be 2.57%.
Shares Statistics:
For the past three months, NGNE has traded an average of 136.18K shares per day and 277420 over the past ten days. A total of 12.82M shares are outstanding, with a floating share count of 10.28M. Insiders hold about 20.86% of the company’s shares, while institutions hold 96.95% stake in the company. Shares short for NGNE as of 1728950400 were 934605 with a Short Ratio of 6.71, compared to 1726185600 on 1792561. Therefore, it implies a Short% of Shares Outstanding of 934605 and a Short% of Float of 8.05.
